YU2397A - 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining - Google Patents

2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining

Info

Publication number
YU2397A
YU2397A YU2397A YU2397A YU2397A YU 2397 A YU2397 A YU 2397A YU 2397 A YU2397 A YU 2397A YU 2397 A YU2397 A YU 2397A YU 2397 A YU2397 A YU 2397A
Authority
YU
Yugoslavia
Prior art keywords
phenyl
aroylbenzothiophenes
medicaments
obtaining
hexamethyleneimino
Prior art date
Application number
YU2397A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Maria Luisa Brandi
Francesco Tonelli
Original Assignee
Eli Lilly Company
Lilly Corporate Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Eli Lilly Company, Lilly Corporate Center filed Critical Eli Lilly Company
Publication of YU2397A publication Critical patent/YU2397A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
YU2397A 1996-01-29 1997-01-24 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining YU2397A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors

Publications (1)

Publication Number Publication Date
YU2397A true YU2397A (en) 1999-11-22

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2397A YU2397A (en) 1996-01-29 1997-01-24 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining

Country Status (19)

Country Link
EP (1) EP0921799A4 (sr)
JP (1) JP2000503994A (sr)
KR (1) KR19990082054A (sr)
CN (1) CN1209745A (sr)
AR (1) AR010978A1 (sr)
AU (1) AU707892B2 (sr)
BR (1) BR9700778A (sr)
CO (1) CO4761062A1 (sr)
CZ (1) CZ235498A3 (sr)
EA (1) EA001104B1 (sr)
ID (1) ID15917A (sr)
IL (1) IL125521A (sr)
MX (1) MX9806036A (sr)
NO (1) NO983451L (sr)
NZ (1) NZ331105A (sr)
PL (1) PL328147A1 (sr)
TW (1) TW446560B (sr)
WO (1) WO1997026877A1 (sr)
YU (1) YU2397A (sr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
CZ253694A3 (en) * 1993-10-15 1995-05-17 Lilly Co Eli Pharmaceutical preparation for treating resistant neoplasms
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
CN1209745A (zh) 1999-03-03
WO1997026877A1 (en) 1997-07-31
IL125521A0 (en) 1999-03-12
EP0921799A1 (en) 1999-06-16
IL125521A (en) 2001-11-25
BR9700778A (pt) 1998-10-06
CO4761062A1 (es) 1999-04-27
TW446560B (en) 2001-07-21
ID15917A (id) 1997-08-21
MX9806036A (es) 1998-11-29
EP0921799A4 (en) 2002-03-13
EA199800677A1 (ru) 1999-02-25
NO983451D0 (no) 1998-07-27
EA001104B1 (ru) 2000-10-30
AU707892B2 (en) 1999-07-22
JP2000503994A (ja) 2000-04-04
CZ235498A3 (cs) 1999-02-17
AR010978A1 (es) 2000-08-02
AU2123997A (en) 1997-08-20
NO983451L (no) 1998-07-27
NZ331105A (en) 2000-06-23
KR19990082054A (ko) 1999-11-15
PL328147A1 (en) 1999-01-18

Similar Documents

Publication Publication Date Title
YU35697A (en) Substituted 6,6-hetero-bicyclic derivatives
MY132251A (en) Methods of inhibiting cell-cell adhesion
NO944876L (no) Sammensetning for behandling av menstruelle symptomer
YU69902A (sh) Novi derivati piperazina
MX9800577A (es) Derivados de 4,5-diaril oxazol.
EA200000731A1 (ru) Альфа-аминоамидные производные, полезные в качестве анальгетических агентов
UA27883C2 (uk) Засіб для інгібування небажаного відкладання фіброїдних тканин на стінці матки
UA32427C2 (uk) Застосування бензотіофенів або їх фармацевтично прийнятних солей або сольватів для інгібування ангіогенезу і/або ангіогенних захворювань
ES2147399T3 (es) Nuevos derivados de 2,3,5-trimetil-4-hidroxianilidas, su preparacion y su aplicacion terapeutica.
IL115014A0 (en) Methods of inhibiting viral replication
DE69412049D1 (de) Hemmung von dysfunctionalen Uterusblutungen
UA39941C2 (uk) Засіб для інгібування окислення ліпопротеїну низької щільності, засіб для приглушення атеросклерозу та засіб для приглушення ішемічної хвороби серця атеросклеротичного походження
WO2000037464A3 (en) 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
HRP20000585B1 (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
DK0652004T3 (da) Fremgangsmåder til behandling af resistente neoplasmer
FR2702477B1 (fr) Dérivés de benzoxazine, leur préparation et leur application en thérapeutique.
YU6996A (sh) Upotreba benzotiofena za dobijanje leka
EA199800015A1 (ru) Способ ингибирования меланомы
CO4650039A1 (es) Benzotiofenos amorfos, procedimientos de preparacion y procedimientos de uso
YU52498A (sh) UPOTREBA 2-ARILBENZO (b) TIOFENA ZA DOBIJANJE LEKA
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
YU55495A (sh) Upotreba benzotiofena za dobijanje leka
MX9701333A (es) Metodos para inhibir el daño neuronal.
DK0904783T3 (da) Benzoe(b)thiophen derivater til sænkning af blodpladetælling
MY113757A (en) Methods of inhibiting endometrial cancer